Variant report
Variant | esv1796784 |
---|---|
Chromosome Location | chr10:27225991-27228473 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:27)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:27 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr10:27226988-27227113 | A549 | lung: | n/a | n/a |
2 | CHD1 | chr10:27228380-27228580 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | CTCF | chr10:27226098-27226178 | GM12878 | blood: | n/a | n/a |
4 | CTCF | chr10:27225900-27226050 | GM12872 | blood: | n/a | n/a |
5 | CTCF | chr10:27226076-27226183 | MCF-7 | breast: | n/a | n/a |
6 | CTCF | chr10:27226080-27226230 | GM12868 | blood: | n/a | n/a |
7 | CTCF | chr10:27226069-27226163 | MCF-7 | breast: | n/a | n/a |
8 | CTCF | chr10:27228220-27228370 | GM12864 | blood: | n/a | n/a |
9 | CTCF | chr10:27226074-27226177 | GM12892 | blood: | n/a | n/a |
10 | CTCF | chr10:27226065-27226184 | MCF-7 | breast: | n/a | n/a |
11 | CTCF | chr10:27226099-27226179 | GM12891 | blood: | n/a | n/a |
12 | CTCF | chr10:27228220-27228370 | GM12865 | blood: | n/a | n/a |
13 | CTCF | chr10:27226080-27226230 | GM12872 | blood: | n/a | n/a |
14 | CTCF | chr10:27228340-27228490 | GM12870 | blood: | n/a | n/a |
15 | CTCF | chr10:27226060-27226210 | GM12865 | blood: | n/a | n/a |
16 | CTCF | chr10:27226020-27226170 | GM12875 | blood: | n/a | n/a |
17 | FOS | chr10:27227608-27227901 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | FOS | chr10:27227605-27227742 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | JUND | chr10:27227608-27227917 | H1-hESC | embryonic stem cell: | n/a | n/a |
20 | JUND | chr10:27228426-27228625 | H1-hESC | embryonic stem cell: | n/a | n/a |
21 | POLR2A | chr10:27228310-27228346 | MCF-7 | breast: | n/a | n/a |
22 | POLR2A | chr10:27228360-27228397 | MCF-7 | breast: | n/a | n/a |
23 | POLR2A | chr10:27228405-27228460 | MCF-7 | breast: | n/a | n/a |
24 | POLR2A | chr10:27228404-27228491 | MCF-7 | breast: | n/a | n/a |
25 | POLR2A | chr10:27228299-27228308 | MCF-7 | breast: | n/a | n/a |
26 | STAT3 | chr10:27226975-27227232 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | STAT3 | chr10:27227594-27227794 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:27228167..27230462-chr10:27233630..27235621,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
LINC00202-1 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4749199 | chr10:27225991-27225992 | ZNF genes & repeats Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs546218701 | chr10:27225993-27225994 | ZNF genes & repeats Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs183112158 | chr10:27225998-27225999 | ZNF genes & repeats Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs113860286 | chr10:27226005-27226006 | ZNF genes & repeats Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs144413217 | chr10:27226083-27226084 | ZNF genes & repeats Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs571708775 | chr10:27226102-27226103 | ZNF genes & repeats Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs187355202 | chr10:27226117-27226118 | ZNF genes & repeats Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs540906853 | chr10:27226119-27226120 | ZNF genes & repeats Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs11015395 | chr10:27226142-27226143 | ZNF genes & repeats Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs572818673 | chr10:27226143-27226144 | ZNF genes & repeats Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs146593205 | chr10:27226160-27226161 | ZNF genes & repeats Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs536630997 | chr10:27226161-27226162 | ZNF genes & repeats Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs553056207 | chr10:27226171-27226172 | ZNF genes & repeats Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs544770330 | chr10:27226172-27226173 | ZNF genes & repeats Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs373709453 | chr10:27226182-27226183 | ZNF genes & repeats Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs558826043 | chr10:27226237-27226238 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575089363 | chr10:27226268-27226269 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs561450478 | chr10:27226302-27226303 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs4749200 | chr10:27226305-27226306 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs555612969 | chr10:27226354-27226355 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs140313605 | chr10:27226361-27226362 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs141545333 | chr10:27226381-27226382 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs386742195 | chr10:27226382-27226383 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs191813192 | chr10:27226383-27226384 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs11015396 | chr10:27226407-27226408 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs532142369 | chr10:27226430-27226431 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs545366989 | chr10:27226431-27226432 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs184313089 | chr10:27226445-27226446 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs188247187 | chr10:27226466-27226467 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs551228515 | chr10:27226482-27226483 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs77564328 | chr10:27226489-27226490 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs76470502 | chr10:27226491-27226492 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs567873500 | chr10:27226496-27226497 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs144037721 | chr10:27226502-27226503 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs547076456 | chr10:27226561-27226562 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs115947810 | chr10:27226568-27226569 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs4749201 | chr10:27226569-27226570 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs201296437 | chr10:27226606-27226607 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs558571149 | chr10:27226614-27226615 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs527673311 | chr10:27226618-27226619 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs111493396 | chr10:27226655-27226656 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs376435002 | chr10:27226684-27226685 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs367839768 | chr10:27226715-27226716 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs374221320 | chr10:27226758-27226759 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs368120198 | chr10:27226759-27226760 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs374123423 | chr10:27226761-27226762 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs74952543 | chr10:27226787-27226788 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs144911934 | chr10:27226794-27226795 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs78027614 | chr10:27226804-27226805 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs371364271 | chr10:27226843-27226844 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Behavioral abnormalities | 21522184 | CNVD |
Dysmorphic features | 21522184 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 21439084 | CNVD |
Maculopathy | 20981449 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
Breast cancer | 21364760 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:27220600-27228000 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
2 | chr10:27220600-27234200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr10:27220800-27226400 | Weak transcription | Fetal Muscle Leg | muscle |
4 | chr10:27220800-27235200 | Weak transcription | Gastric | stomach |
5 | chr10:27225800-27226200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr10:27225800-27226600 | Enhancers | Fetal Muscle Trunk | muscle |
7 | chr10:27226200-27228200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr10:27226400-27226600 | Enhancers | Fetal Muscle Leg | muscle |
9 | chr10:27226600-27227400 | Weak transcription | Fetal Muscle Trunk | muscle |
10 | chr10:27226600-27228600 | Active TSS | Fetal Muscle Leg | muscle |
11 | chr10:27227400-27228000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr10:27227400-27228800 | Active TSS | Fetal Muscle Trunk | muscle |
13 | chr10:27227800-27228400 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
14 | chr10:27227800-27228600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr10:27227800-27229200 | Active TSS | Skeletal Muscle Male | skeletal muscle |
16 | chr10:27228000-27229200 | ZNF genes & repeats | Foreskin Melanocyte Primary Cells skin01 | Skin |
17 | chr10:27228200-27229000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
18 | chr10:27228200-27235200 | Weak transcription | Right Atrium | heart |
19 | chr10:27228400-27230200 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |